abagovomab 42
abciximab 34
abituzumab 28
abrilumab 24
actoxumab 27
adalimumab 17
aducanumab 18
afasevikumab 20
alacizumab_pegol 12
alemtuzumab 35
alirocumab 25
amatuximab 51
andecaliximab 28
anifrolumab 28
anrukinzumab 18
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 25
ascrinvacumab 13
atezolizumab 16
atinumab 20
avelumab 20
basiliximab 50
bavituximab 42
begelomab 36
benralizumab 36
bevacizumab_beta 24
bezlotoxumab 27
bimagrumab 25
bleselumab 27
blinatumomab 46
blosozumab 31
bococizumab 25
brazikumab 20
brentuximab_vedotin 43
briakinumab 21
brodalumab 21
brolucizumab 30
brontictuzumab 31
burosumab 26
cabiralizumab 34
camrelizumab 15
canakinumab 25
cantuzumab_ravtansin 46
carlumab 23
carotuximab 26
cergutuzumab_amunaleukin2 32
cergutuzumab_amunaleukin 32
certolizumab_pegol 27
cetiximab 48
citatuzumab_bogatox 31
cixutumumab 36
clivatuzumab_tetraxetan 23
codrituzumab 35
conatumumab 21
concizumab 32
crenezumab 23
crizanlizumab 31
crotedumab 24
dacetuzumab 24
daclizumab 19
dalotuzumab 32
dapirolizumab_pegol 27
daratumumab 17
dectrekumab 12
demcizumab 33
denosumab 9
depatuxizumab 27
depatuxizumab_mafodotin 27
dezamizumab 29
dinutuximab 40
diridavumab 24
domagrozumab 19
drozitumab 25
duligotuzumab 20
durvalumab 18
dusigitumab 31
efalizumab 37
efungumab 31
eldelumab 23
elezanumab 29
elgemtumab 14
elotuzumab 19
emactuzumab 28
emapalumab 32
emibetuzumab 26
enavatuzumab 27
enfortumab_vedotin 16
enoblituzumab 20
enokizumab 30
enoticumab 24
ensituximab 44
eptinezumab 18
erenumab 30
etaracizumab 18
etrolizumab 23
evinacumab 25
evolocumab 28
farletuzumab 6
fasinumab 30
fezakinumab 29
fibatuzumab 21
ficlatuzumab 29
firivumab 35
flanvotumab 29
fletikumab 37
foralumab 18
foravirumab 18
fremanezumab 35
fresolimumab 22
fulranumab 23
futuximab 28
galcanezumab 25
ganitumab 26
gantenerumab 17
gemetuzumab 38
gemtuzumab2 32
gemtuzumab 32
gevokizumab 28
girentuximab 32
glembatumumab 26
glembatumumab_vedotin 26
guselkumab 27
ibalizumab 34
ibritumomab 43
icrucumab 15
idarucizumab 37
ifabotuzumab 21
imalumab 18
imgatuzumab 27
inclacumab 26
indatuximab_ravtansin 34
indusatumab 22
inebilizumab 28
intetumumab 20
iodine_girentuximab 31
ipilimumab 12
iratumumab 21
isatuximab 39
itolizumab 27
ixekizumab 39
labetuzumab_govitecan 27
lambrolizumab 35
lampalizumab 30
lanadelumab 21
landogrozumab 21
laprituximab 36
lebrikizumab 39
lendalizumab 31
lenzilumab 27
lifastuzumab_vedotin 25
ligelizumab 28
lilotomab 43
lirilumab 33
lodelcizumab 25
lokivetmab 27
lorvotuzumab_mertansin 24
lucatumumab 33
lumretuzumab 28
lupartumab 20
lutikizumab 19
margetuximab 36
milatuzumab 44
mirvetuximab 40
mirvetuximab_soravtansin 40
modotuximab 48
mogamulizumab 29
monalizumab 33
motavizumab 37
moxetumomab_pasudotox 26
namilumab 28
naratuximab 37
naratuximab_emtansin 37
narnatumab 22
navicixizumab2 32
navicixizumab 35
navivumab 38
necitumumab 17
nemolizumab 31
nesvacumab 17
nivolumab 18
obiltoxaximab 27
obinutuzumab 35
ocaratuzumab 32
ofatumumab 22
olaratumab 27
olokizumab 24
omalizumab 23
onartuzumab 25
ontuxizumab 36
opicinumab 16
orticumab 14
otelixizumab 40
oxelumab 15
ozanezumab 37
pamrevlumab 15
panobacumab 25
parsatuzumab 32
pasotuxizumab 22
pateclizumab 20
patritumab 22
pembrolizumab 35
perakizumab 26
pidilizumab 23
pinatuzumab_vedotin 20
plozalizumab 27
pogalizumab 32
polatuzumab_vedotin 23
ponezumab 38
prezalumab 17
pritoxaximab 46
quilizumab 21
racotumomab 36
radretumab 20
ralpancizumab 29
ramucirumab 15
ranevetmab 33
ranibizumab 24
refanezumab 29
remtolumab 20
rilotumumab 22
rinucumab 21
risankizumab 36
rituximab 28
rivabazumab 26
robatumumab 22
roledumab 33
romosozumab 30
rontalizumab 26
rosmantuzumab 29
rozanolixizumab 24
sacituzumab 33
sacituzumab_govitecan 33
samalizumab 32
sapelizumab 25
sarilumab 19
secukinumab 21
seribantumab 20
setoxaximab 47
sifalimumab 20
siltuximab 22
simtuzumab 34
sirukumab 16
solanezumab 29
solitomab 33
stamulumab 26
suptavumab 31
suvizumab 22
tabalumab 26
tadocizumab 22
tamtuvetmab 36
tanezumab 27
tarextumab 13
tavolixizumab 16
telisotuzumab 36
teplizumab 25
tesidolumab 29
tezepelumab 34
tigatuzumab 17
tildrakizumab 29
timolumab 18
tisotumab 14
tosatoxumab 37
tositumomab 40
tralokinumab 42
trastuzumab 25
tregalizumab 23
trevogrumab 12
ublituximab 38
urelumab 26
ustekinumab 32
utomilumab 39
vadastuximab 35
vadastuximab_talirin 35
vandortuzumab_vedotin 24
vantictumab 29
vanucizumab2 24
vanucizumab 42
varlilumab 19
vatelizumab 26
vedolizumab 35
veltuzumab 22
vesencumab 14
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 39
xentuzumab 20
zatuximab 48
